Vinoth-Kumar Lakshmanan (Young Do Jung)

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Venues

Scientific reports

Antioxidants (Basel, Switzerland)

Cancer gene therapy

Chemical biology & drug design

This page only lists publications with an associated author ORCID identifier.

Publications

Gulzar Ahmed Rather, Preethi Selvakumar, K Satish Srinivas, K Natarajan, Ajeet Kaushik, Prabhakar Rajan, Seung-Rock Lee, Wong Ling Sing, Mohammad Alkhamees, Sen Lian, Merrel Holley, Vinoth-Kumar Lakshmanan, Vinoth-Kumar Lakshmanan
Facile synthesis of elastin nanogels encapsulated decursin for castrated resistance prostate cancer therapy. Scientific reports 14 (1) (2024)
Gulzar Ahmed Rather, Preethi Selvakumar, K Satish Srinivas, K Natarajan, Ajeet Kaushik, Prabhakar Rajan, Seung-Rock Lee, Wong Ling Sing, Mohammad Alkhamees, Sen Lian, Merrel Holley, Vinoth-Kumar Lakshmanan, Vinoth-Kumar Lakshmanan
Facile synthesis of elastin nanogels encapsulated decursin for castrated resistance prostate cancer therapy. Scientific reports 14 (1) (2024)
Gulzar Ahmed Rather, Preethi Selvakumar, K Satish Srinivas, K Natarajan, Ajeet Kaushik, Prabhakar Rajan, Seung-Rock Lee, Wong Ling Sing, Mohammad Alkhamees, Sen Lian, Merrel Holley, Vinoth-Kumar Lakshmanan, Vinoth-Kumar Lakshmanan
Facile synthesis of elastin nanogels encapsulated decursin for castrated resistance prostate cancer therapy. Scientific reports 14 (1) (2024)
Gulzar Ahmed Rather, Preethi Selvakumar, K Satish Srinivas, K Natarajan, Ajeet Kaushik, Prabhakar Rajan, Seung-Rock Lee, Wong Ling Sing, Mohammad Alkhamees, Sen Lian, Merrel Holley, Vinoth-Kumar Lakshmanan, Vinoth-Kumar Lakshmanan
Facile synthesis of elastin nanogels encapsulated decursin for castrated resistance prostate cancer therapy. Scientific reports 14 (1) (2024)
Vinoth-Kumar Lakshmanan, Mahesh Desai
New insights on the early prostate cancer diagnosis in a real-world setting. Investigative and clinical urology 63 (3) (2022)
Shinan Li, Thi Thinh Nguyen, Trong Thuan Ung, Dhiraj Kumar Sah, Seon Young Park, Vinoth-Kumar Lakshmanan, Young Do Jung
Piperine Attenuates Lithocholic Acid-Stimulated Interleukin-8 by Suppressing Src/EGFR and Reactive Oxygen Species in Human Colorectal Cancer Cells. Antioxidants (Basel, Switzerland) 11 (3) (2022)
Vinoth-Kumar Lakshmanan, Shlok Jindal, Gopinath Packirisamy, Shreesh Ojha, Sen Lian, Ajeet Kaushik, Abdulqadir Ismail M Abdullah Alzarooni, Yasser Abdelraouf Farahat Metwally, Sadras Panchatcharam Thyagarajan, Young Do Jung, Salem Chouaib
Nanomedicine-based cancer immunotherapy: recent trends and future perspectives. Cancer gene therapy 28 (9) (2021)
M F Nagoor Meeran, Azim Ullah Shamsul Islam, M Marzouq Al Ahbabi, Niraj Kumar Jha, Vinoth-Kumar Lakshmanan, Sameer N Goyal, Shreesh Kumar Ojha
Nootkatone, a Dietary Fragrant Bioactive Compound, Attenuates Dyslipidemia and Intramyocardial Lipid Accumulation and Favorably Alters Lipid Metabolism in a Rat Model of Myocardial Injury: An In Vivo and In Vitro Study. Molecules (Basel, Switzerland) 25 (23) (2020)
Gopalakrishnan Chandrasekaran, Eu Chang Hwang, Taek Won Kang, Dong Deuk Kwon, Kwangsung Park, Je-Jung Lee, Vinoth-Kumar Lakshmanan
In silico analysis of the deleterious nsSNPs (missense) in the homeobox domain of human HOXB13 gene responsible for hereditary prostate cancer. Chemical biology & drug design 90 (2) (2017)

Vinoth-Kumar Lakshmanan.css-eqlu8i{font-size:small;padding-left:4px;} (Young Do Jung)

Publication Activity (10 Years)

Top Topics

Top Venues

Vinoth-Kumar Lakshmanan (Young Do Jung)